GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
337.31
-2.70 (-0.79%)
At close: Nov 6, 2026

GlaxoSmithKline Pakistan Cash Flow Statement

Millions PKR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
10,98410,0256,536533.952,4635,354
Depreciation & Amortization
1,3741,3741,136932.3859.38775.27
Loss (Gain) From Sale of Assets
-74.07-74.07-21.88-82.76-124.62-633.9
Asset Writedown & Restructuring Costs
42.0142.0118.396.0118.0215.54
Provision & Write-off of Bad Debts
21.5121.511.76160.3489.742.74
Other Operating Activities
-820.02180.421,552-703.15-431.511,204
Change in Accounts Receivable
-2,279-2,279471.58395.71-358.67-154.15
Change in Inventory
-2,739-2,739-365.39-2,256-3,363-1,077
Change in Accounts Payable
557.26557.26-1,0094,3322,827-36.69
Change in Other Net Operating Assets
1,5551,555-3,257-1,386-5,142-512.05
Operating Cash Flow
8,5958,6645,0581,884-3,1614,987
Operating Cash Flow Growth
20.40%71.30%168.51%---16.33%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2,287-2,583-2,775-1,649-1,533-1,304
Sale of Property, Plant & Equipment
245.84275.65134.32212.95244.47777.27
Other Investing Activities
675.64518.14538.91279.45827.1374.94
Investing Cash Flow
-1,366-1,789-2,102-1,157-461.6-151.56

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--54.31-51.12-25.59-14.6-11.46
Lease Payments
-78.4-54.31-51.12-25.59-14.6-11.46
Net Debt Issued (Repaid)
-78.4-54.31-51.12-25.59-14.6-11.46
Common Dividends Paid
-6,012-4,742-1.76-1,845-375.03-2,062
Financing Cash Flow
-6,091-4,796-52.88-1,871-389.63-2,073

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
1,1382,0792,903-1,144-4,0122,762

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
6,3076,0812,282234.56-4,6943,683
Free Cash Flow Growth
44.10%166.44%873.04%---20.69%
Free Cash Flow Margin
9.07%9.23%3.73%0.47%-11.22%10.05%
Free Cash Flow Per Share
19.8119.097.170.74-14.7411.57
Levered Free Cash Flow
7,5546,7583,051-1,126-1,4733,545
Unlevered Free Cash Flow
7,5546,7853,063-1,122-1,4703,549
Free Cash Flow After Leases
6,2296,0272,231208.97-4,7093,672

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
9,1627,2842,6982,3092,639871.59
Change in Working Capital
-2,906-2,906-4,1601,085-6,036-1,780